TerminatedNot Applicable

Glucose Metabolism Disorders and Metabolic Syndrome Before and After Primary Hip and Knee Replacement

Stopped: Primary researcher not able to continue research at the moment.

Finland155 participantsStarted 2012-04

Plain-language summary

Osteoarthritis patients undergoing primary hip and knee replacement are followed-up and changes in their glucose metabolism and other metabolic parameters (obesity, cholesterol levels) are examined. Persistent postoperative pain is examined as secondary outcome.

Who can participate

Age range18 Years – 120 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Primary hip and knee replacement for osteoarthritis * Enrolled previously into study NCT01021826 Exclusion Criteria: * Arthritis other than osteoarthritis (based on study NCT01021826) * Medication affecting glucose metabolism (excl. antidiabetic agents) (based on study NTC01021826) * Died before follow-up phase * Did not undergo the planned hip or knee replacement

What they're measuring

Change in glucose tolerance, measured using oral glucose tolerance test

Timeframe: Baseline and 12-24 months after surgery

Trial details

NCT IDNCT01743313

SponsorCoxa, Hospital for Joint Replacement

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2012-08

View on ClinicalTrials.gov More Hyperglycemia trials